Fig. 4From: Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRIRepresentative sections of HE, HER2, TUNEL, E-cadherin and CD31 & α-SMA double staining in the four groups. HE, haematoxylin and eosin; HER2, human epidermal growth Factor 2; TUNEL, terminal-deoxynucleotidyl transferase mediated nick end labellingBack to article page